Genetic Testing Tools
Search documents
Illumina (ILMN) Reliance on International Sales: What Investors Need to Know
ZACKSยท 2025-08-05 14:16
Core Insights - The performance of Illumina's international operations is crucial for understanding its financial strength and growth potential [1][2] - The company's reliance on international markets is a key factor in determining its financial success and growth trajectory [2][3] International Revenue Analysis - For the quarter ending June 2025, Illumina's total revenue was $1.06 billion, a decline of 4.8% year over year [4] - Europe contributed $310 million, accounting for 29.3% of total revenue, exceeding analyst expectations of $293.21 million [5] - Greater China accounted for 6% of total revenue, translating to $63 million, slightly above the expected $62.52 million [6] Revenue Projections - Analysts project Illumina's revenues for the ongoing fiscal quarter to be $1.06 billion, a decline of 1.8% from the previous year, with expected contributions from Europe at 27.9% ($296.38 million) and Greater China at 4% ($42.13 million) [7] - For the full year, total revenue is projected to be $4.27 billion, a decrease of 2.4% from last year, with Europe expected to contribute $1.19 billion (27.8%) and Greater China $219.82 million (5.2%) [8] Conclusion on International Revenue Trends - Illumina's reliance on international markets presents both opportunities and challenges, making it essential to track international revenue trends for future projections [9][10]